New York, NYNCT06808477Now EnrollingIRB Ready

Atopic Dermatitis Clinical Trial in New York, NY

Access cutting-edge atopic dermatitis treatment through this phase 1 clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by Bambusa Therapeutics

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions…

Expert Care in New York

Access atopic dermatitis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related atopic dermatitis treatment provided free

Apply for This New York Location

Check if you qualify for this atopic dermatitis clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This Atopic Dermatitis Study in New York

This is a Phase 1, randomized, blinded, placebo controlled, single-ascending dose (SAD) and multiple-ascending dose (MAD) study of BBT001 in healthy volunteers (HVs) and adult patients with moderate to severe Atopic Dermatitis (AD).

Sponsor: Bambusa Therapeutics

Who Can Participate

Inclusion Criteria

Negative pregnancy tests for women of childbearing potential.
Willingness to refrain from alcohol consumption for 24 hours prior to each study visit.
Non-smokers, healthy current smokers (≤5 cigarettes/day), or ex-smokers.
Adequate contraception use (for men and women of childbearing potential). Key Inclusion Criteria (Parts A, B, and D)
Age of 18-65 years.
Body mass index of 18 to 32 kg/m², weight capped at 120 kg.
No clinically significant abnormalities or history of relevant diseases. Key Inclusion Criteria (Parts C and E only)
Age of 18-72 years.
Body mass index ≥16 kg/m², weight capped at 125 kg.
Must have dermatologist-confirmed chronic atopic dermatitis (≥12 months). Inadequate response to topical treatments or where they are medically inadvisable.
Moderate to severe atopic dermatitis
Validated investigator's global assessment for atopic dermatitis (vIGA-ADTM) score ≥3
Atopic lesions cover ≥10% of body surface area (BSA)
Average peak pruritus numeric rating scale (PP-NRS) score ≥4 in the 7 days before randomization. Key

Exclusion Criteria

Significant health issues, such as: diabetes, positive tests for human immunodeficiency virus (HIV), hepatitis C virus (HCV), or hepatitis B surface antigen (HBsAg), immunodeficiencies, autoimmune diseases, or cancer, history of conditions predisposing to infections.
History of major metabolic, dermatological, liver, kidney, hematological, or other significant disorders.
Clinically relevant abnormal lab results, including low blood counts, liver issues, or abnormal kidney function.
Positive drug/alcohol tests or abnormal vital signs at screening or Day -1.
Abnormal Electrocardiogram (ECG) findings
History of drug/alcohol abuse in the past 2 years.
Donated \>500mL blood within 2 months of screening.
History of severe allergic reactions or hypersensitivity. Key Exclusion Criteria (Parts A, B, and D only) 1\. History of atopic dermatitis Key Exclusion Criteria (Parts C and E only)
Skin diseases other than atopic dermatitis, significant tattoos, or scarring.
Receipt of immunoglobulin or blood products within 30 days.
Atopic dermatitis with ocular symptoms or chronic ocular steroid use.
Chronic pruritus from conditions other than atopic dermatitis.
Acute/treated infections or chronic skin infections.
Current use of sedating antihistamines or corticosteroids.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT06808477) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Atopic Dermatitis Treatment Options in New York, NY

If you're searching for atopic dermatitis treatment options in New York, NY, this clinical trial (NCT06808477) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this phase 1 clinical trial. You'll receive care from experienced atopic dermatitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all atopic dermatitis clinical trials near you to find additional studies recruiting in your area.

More Atopic Dermatitis Trials in New York, NY

See all atopic dermatitis clinical trials recruiting in New York — not just this study.

Browse Atopic Dermatitis Trials in New York →

Browse More Trials by Condition

Atopic Dermatitis TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY